GPD2 and neoplasm: Consistent with the in vitro result, the KO cell-derived tumors progressed significantly slower than tumors derived from their WT counterparts (Figures 2G-I). These results confirm the positive role of GPD2 in tumor progression, and inhibition of GPD2 may work as a therapeutic target for the cancer.